|
Quigley
Pharma
Mission
| Officers
| News Releases | Resources
| Contact Us
The
Corporate Officers of Quigley Pharma
Under
the leadership of Quigley Pharma's Chief Operating Officer,
Richard Rosenbloom, MD, Ph.D., the company will be pursuing
its main interest, which is medical discovery. Management's
attention is upon therapeutic areas that have not been successfully
covered by major pharmaceutical companies. Quigley Pharma's
officers consult with scientific and clinical opinion leaders
who provide valuable feedback in the drug development process,
therapeutic needs and regulatory benchmarks. Partnerships
with university and independent researchers to facilitate
research and development goals are being established. Management
is constantly reminded of the patients who desperately need
the new products. Our response is to apply our full attention
to getting these new products approved and on the market as
soon as possible.
Guy
J. Quigley | Charles
Phillips | Richard Rosenbloom
George Longo
|
